Please wait...

Learn

Finding accredited CPD

Psoriasis Research Review Issue 127

Description

Psoriasis Research Review Issue 127 with commentary by Associate Professor John Frew.

This review is a unique Australian publication providing topical, relevant and accessible information for health professionals with an interest in psoriasis. In essence, the review is a summary of what we consider to be some of the most significant new studies in this area.

Details

In this edition we feature:

- Systemic psoriasis therapy and COVID-19 outcomes

- Psoriatic arthritis assessment and documentation

- Mortality risk in generalised pustular psoriasis

- Lifestyle metabolites and risk of late-onset psoriasis

- Drug survival of systemic treatments in paediatric psoriasis

- Route of methotrexate administration in psoriasis

- Apremilast for genital psoriasis

- Smoking cessation, weight change and psoriasis risk

- Cumulative life course impairment in psoriasis

- Long-term patient-reported outcomes with bimekizumab.

To access this publication please click ‘Enrol Now’ and you’ll be directed to the publication. Then sign up to Research Review at no cost. You can then login with your email and password. If you require any assistance please email Research Review – trish@researchreview.com.au

This activity is accepted by CPD Home as a Domain 1: Educational Activity - Professional Reading in alignment with the CPD Home Program Guide.

Disclaimer: Please note, once you click 'Enrol now' you will be leaving the AMA’s CPD Home website and entering a third-party website.

Provided by

CPD Activity Details

Topic

Dermatology

CAPE Aspects

Effective Year

Educational Activities (EA) - 0.30

Reviewing Performance (RP) - 0.0

Measuring Outcomes (MO) - 0.0

You have to log in to see the content of this module.